Lloyds Clinical

Lloyds Clinical: specialist clinical care at home

Lloyds Clinical is a provider of specialist clinical services delivered outside hospital, mainly in patients' homes and in their community setting. The company presents itself as one of the UK's most experienced providers in this field and states that its clinical teams help patients manage their condition at home or in the community.

With almost 30 years of activity, the company says it has pioneered access to clinical treatments outside hospital. Its offering combines dispensing and delivery of medication with specialist nursing, and covers the largest number of therapeutic areas and complex conditions treated outside hospital, according to its own presentation.

Services for the NHS

Lloyds Clinical works with the British National Health Service (NHS) and with other partners in the healthcare system. In this area it offers compounded nurse-led treatments and non-compounded treatments, also nurse-led.

Among the compounded treatments it mentions are cancer care, home parenteral nutrition and thalassaemia. In the non-compounded group it includes rheumatology, rare disorders, enzyme replacement therapy, immunoglobulin deficiency and outpatient antibiotic treatment.

The company also provides dispensing and delivery services for oral cancer (SACT), gastroenterology, growth hormone deficiency, multiple sclerosis, respiratory disease and osteoporosis.

Clinical support services

In addition to treatments, Lloyds Clinical offers a range of support services that accompany home care:

• Chronic disease management.
• On-call service available 24 hours.
• Phlebotomy services.
• Electronic signature (eSign).
• Remote nurse training.
• Patient support programs and adherence management.

The company highlights that its 24-hour on-call service allows patients to contact it day and night. According to the data it publishes, 99% of doses or treatments are delivered on time and 98% of deliveries arrive within two hours of the assigned slot. It adds that, in the last five months, its clinical teams prevented 29 hospital admissions.

Specialist cancer care

Lloyds Clinical has specific specialist cancer care services and offers private cancer treatment at home. The company enables private hospitals to refer cancer patients for home treatment and presents its model as a way to maximise capacity and margins at those centres.

Among the types of cancer it mentions in its information are skin, prostate, breast, lung, kidney and bowel cancer. It also includes frequently asked questions aimed at understanding the diagnosis and treatment options.

Home parenteral nutrition

Home parenteral nutrition (HPN) is one of the company's highlighted areas. Lloyds Clinical has specialist in-house teams that support clinicians and patients in the transition from hospital to home.

The company publishes content on the clinical decisions that make personalised care possible and on the work of the professionals involved beyond the delivery of parenteral nutrition itself. It also addresses planning the transition of young patients receiving HPN.

Aseptic compounding

Lloyds Clinical has a qualified team that works to the highest regulatory standards, according to its presentation. The aseptic compounding service includes the preparation of cytotoxic medicines, monoclonal antibodies, systemic anti-cancer treatment and IV antibiotics.

The company states that it has been awarded the NHS framework agreement for aseptically prepared cytotoxic medicines and monoclonal antibodies for cancer treatment.

Collaboration with the pharmaceutical industry

The company works with pharmaceutical and biotech companies across the drug lifecycle. Its offering in this area includes market access and understanding to facilitate therapeutic breakthroughs.

Healthcare centres and international activity

Lloyds Clinical operates several healthcare centres in the UK. Among those it mentions are Velindre, Newcastle and two Royal Surrey centres, in Woking and Horsham.

The company also has activity in Scotland, where it has Care Inspectorate reports, including a duty of candour report for 2022-2023.

Patients and professionals

The company organises its activity around several audiences: patients, partners, healthcare professionals, the NHS and pharmaceutical companies. It has a patient app and a resource hub for those receiving home parenteral nutrition.

Its informative content includes stories of patients who have received cancer treatment or parenteral nutrition at home, as well as profiles of the company's professionals. The company also participates in industry conferences, such as UKONS, BAPEN and BOPA.